GTXI News Alert GTX Inc (GTXI) 0.88 12/17/2014 02:56:21

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
GTX Inc (GTXI) 0.88 $GTXI

Strength Seen in GTX Inc (GTXI): Stock Rises 10.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 8:46AM CST
GTX Inc. (GTXI) was a big mover last session, with shares rising roughly 11% on the day.
BIIB: 325.13 (-10.67), GTXI: 0.88 (+0.11), ANIP: 55.08 (+1.32), AFFX: 8.90 (+0.10)

GTx to Present Results on Enobosarm 9mg in Women with Metastatic Breast Cancer at 2014 San Antonio Breast Cancer Symposium
Business Wire - Mon Dec 08, 7:01AM CST
GTx, Inc. (NASDAQ: GTXI) today announced that the results from its positive proof of concept Phase 2 clinical trial evaluating enobosarm 9mg in post-menopausal women with estrogen receptor (ER) positive and androgen receptor (AR) positive metastatic breast cancer will be featured in a poster presentation at the San Antonio Breast Cancer Symposium taking place December 9 - 13, 2014, in San Antonio, Texas.
GTXI: 0.88 (+0.11)

GTx's USD43.4m private placement closed
M2 - Tue Nov 18, 4:30AM CST
GTx Inc (Nasdaq:GTXI), a biopharmaceutical company, announced on Monday the closing of a private placement of its common stock and warrants to purchase its common stock.
GTXI: 0.88 (+0.11)

GTx Announces Closing of $43.4 Private Placement
Business Wire - Mon Nov 17, 6:00AM CST
GTx, Inc. (NASDAQ: GTXI) today announced that it has closed the previously-announced private placement of its common stock and warrants to purchase its common stock. In the private placement, GTx sold 64,311,112 immediately separable units, comprised of an aggregate of 64,311,112 newly-issued shares of common stock and warrants to purchase up to 64,311,112 additional shares of common stock, for an aggregate purchase price of approximately $43.4 million. Net proceeds to GTx from the private placement are expected to be approximately $42.8 million.
GTXI: 0.88 (+0.11)

GTx Announces Webcast of Corporate Presentation at the Stifel 2014 Healthcare Conference
Business Wire - Wed Nov 12, 6:30AM CST
GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on November 18, 2014, at the Stifel 2014 Healthcare Conference in New York City. The GTx presentation will begin at 3:00 pm EST. A simultaneous webcast of the presentation will be accessible from the GTx website at http://www.gtxinc.com. An archived replay of the presentation will be available on the company website until December 2.
GTXI: 0.88 (+0.11)

GTx's (GTXI) CEO Marc Hanover on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 12:14PM CST

GTXI: 0.88 (+0.11)

GTx net loss improves in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 10:51AM CST

GTXI: 0.88 (+0.11)

GTx (GTXI) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 7:55AM CST

GTXI: 0.88 (+0.11)

GTx beats by $0.05
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 6:18AM CST

GTXI: 0.88 (+0.11)

GTx Provides Corporate Update and Reports Third Quarter 2014 Financial Results
Business Wire - Mon Nov 10, 6:15AM CST
--Closing of recently announced private placement will provide cash through 2016 and key breast cancer milestones
GTXI: 0.88 (+0.11)

GTx Announces $43.4 Million Private Placement
Business Wire - Mon Nov 10, 6:01AM CST
GTx, Inc. (NASDAQ: GTXI) today announced that it has entered into a securities purchase agreement for the sale of approximately $43.4 million of its common stock and warrants to purchase common stock in a private placement. The group of accredited investors includes Biotechnology Value Fund, L. P. and other affiliates of BVF Partners L.P., certain existing GTx stockholders and certain members of the GTx management team and board of directors.
GTXI: 0.88 (+0.11)

Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:30PM CST

BID: 39.25 (-0.15), CRIS: 1.15 (-0.01), KWK: 0.28 (unch), ARQL: 1.16 (unch), CACQ: 8.79 (+0.14), RIG: 16.78 (+0.53), TRQ: 2.80 (-0.01), MPAA: 31.84 (-0.01), RSPP: 20.82 (+0.54), DF: 17.69 (-0.07), ENTR: 2.18 (-0.24), TA: 10.52 (+0.02), DDD: 30.05 (+1.67), RYN: 25.91 (-0.19), GAS: 50.42 (-0.23), CMCM: 14.93 (-0.25), LIOX: 5.46 (-0.05), WWAV: 33.65 (-0.16), ZINC: 14.21 (+0.08), GTXI: 0.88 (+0.11), GOGO: 15.05 (-0.30), RIGP: 15.44 (+0.87), EVEP: 22.63 (+1.16), SNSS: 2.35 (+0.14), MGIC: 6.43 (-0.05)

GTx, Inc. To Host Third Quarter 2014 Financial Results Conference Call and Webcast
Business Wire - Mon Nov 03, 4:00PM CST
GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast to provide a corporate update and discuss the Company's third quarter 2014 financial results on Monday, November 10 at 9:00 a.m. Eastern Time. The call and webcast will follow the release of the financial results earlier that day.
GTXI: 0.88 (+0.11)

Hot Stock: GTx, Shares Drop 6.4% (GTXI)
Comtex SmarTrend(R) - Wed Sep 17, 10:37AM CDT
GTx (NASDAQ:GTXI) is one of today's worst performing penny stocks, down 6.4% to $0.74 on 1.4x average daily volume. GTx has traded 302,000 shares thus far today, vs. average volume of 215,000 shares per day. The stock has underperformed the Dow (-6.3% to the Dow's 0.1%) and underperformed the S&P 500 (-6.3% to the S&P's 0.1%) during today's trading.
GTXI: 0.88 (+0.11)

GTx Announces Webcast of Corporate Presentation at the 2014 Wedbush Pacgrow Life Sciences Management Access Conference
Business Wire - Thu Aug 07, 6:30AM CDT
GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on August 13, 2014, at the 2014 Wedbush Pacgrow Life Sciences Management Access Conference in New York City. The GTx presentation will begin at 2:30 pm EST. A simultaneous webcast of the presentation will be accessible from the GTx website at http://www.gtxinc.com. An archived replay of the presentation will be available on the company website until August 27.
GTXI: 0.88 (+0.11)

Investors look to Lighten Up on Shares of GTx, Shares Down 7.8% (GTXI)
Comtex SmarTrend(R) - Wed Aug 06, 12:42PM CDT
GTx (NASDAQ:GTXI) is one of today's worst performing low-priced stocks, down 7.8% to $1.06 on 1.1x average daily volume. GTx has traded 448,000 shares thus far today, vs. average volume of 419,000 shares per day. The stock has underperformed the Dow (-7.8% to the Dow's 0.2%) and underperformed the S&P 500 (-7.8% to the S&P's 0.2%) during today's trading.
GTXI: 0.88 (+0.11)

GTx Provides Corporate Update and Reports Second Quarter 2014 Financial Results
Business Wire - Tue Aug 05, 6:00AM CDT
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the quarter and six months ended June 30, 2014. The Company also highlighted clinical development progress with enobosarm, an oral selective androgen receptor modulator, as well as progress with GTx-758, its oral nonsteroidal selective estrogen receptor alpha agonist, being studied for secondary hormonal therapy in men with castration-resistant prostate cancer.
GTXI: 0.88 (+0.11)

GTx, Inc. to Report Second Quarter 2014 Financial Results on August 5, 2014
Business Wire - Tue Jul 22, 6:30AM CDT
GTx, Inc. (NASDAQ: GTXI) today announced that the date for its second quarter 2014 financial results press release will be Tuesday, August 5, 2014, prior to the opening of the U.S. stock markets. Similar to the previous quarter, the Company is not planning to host a conference call or webcast on that date, but will continue to provide periodic updates on clinical trial results and other material company developments as appropriate throughout the remainder of the year.
GTXI: 0.88 (+0.11)

4 Biotech Stocks Under $10 to Watch for Breakout Trades
at The Street - Wed Jul 02, 7:18AM CDT
These under-$10 biotech stocks are within range of triggering breakout trades.
GTXI: 0.88 (+0.11), RXDX: 6.62 (+0.34), XOMA: 4.15 (-0.15), MEIP: 3.95 (-0.12)

Corneal Neovascularization - Pipeline Review, H1 2014
M2 - Thu Jun 12, 2:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lld3cs/corneal) has announced the addition of the "Corneal Neovascularization - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Corneal Neovascularization, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Corneal Neovascularization and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope - The report provides a snapshot of the global therapeutic landscape of Corneal Neovascularization - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Corneal Neovascularization and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Corneal Neovascularization products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Companies Mentioned: - F. Hoffmann-La Roche Ltd. - GTx, Inc. - Sirnaomics, Inc. - Amakem NV For more information visit http://www.researchandmarkets.com/research/lld3cs/corneal
GTXI: 0.88 (+0.11)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 126

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 135

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 17

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 134

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 211

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 71

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 28

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading

Top 5 Most Recently Viewed Articles

Equifax Unveils AI Advisory Service for Lenders' Success

Updated Category News Views 308

Empowering Lenders with Equifax Ignite AI Advisor Equifax has recently launched a transformative tool known as the Equifax Ignite AI Advisor, which is set to revolutionize how lenders operate. This innovative product aims to provide lenders with precise, actionable insights that can significantly improve decision-making processes and account growth. By leveraging advanced...

Continue Reading
Daily Overview: Spain's Stocks Experience Positive Surge

Updated Category News Views 153

Spain's Stock Market Closes on a Positive Note On a recent trading day, stocks in Spain showcased an encouraging uptick, particularly noted after the closing bell rang on Friday. The uptrend was primarily driven by gains in various sectors, which included Consumer Goods, Chemical, Petroleum & Plastic, as well as Telecoms & IT. These sectors played a vital role in...

Continue Reading
AGCO Celebrates Tiina Herlevi's 2025 Women MAKE Award Win

Updated Category News Views 195

AGCO Celebrates Leadership in Manufacturing AGCO, an acknowledged leader in the world of agricultural machinery and precision ag technology, has proudly announced that Tiina Herlevi has been honored with the 2025 Women MAKE Award. This prestigious recognition comes as a testament to her unwavering commitment to excellence and innovation within the manufacturing sector....

Continue Reading
eGain Delivers Impressive Q1 2026 Performance and Guidance

Updated Category News Views 206

Introduction to eGain's Financial Journey With an unwavering commitment to enhancing customer experience (CX) through AI automation, eGain Corporation (NASDAQ: EGAN) continues to make significant strides. Recently, eGain reported its fiscal 2026 first quarter results, showcasing impressive growth metrics and an optimistic outlook for the upcoming quarters. Q1 2026...

Continue Reading
Optimize Your Vehicle with Expert Multi-Point Inspection Services

Updated Category News Views 159

Optimize Your Vehicle with Expert Multi-Point Inspection Services Local drivers can take advantage of a multi-point inspection service at Auction Direct USA, designed to ensure their vehicles remain in peak condition. The Importance of Regular Vehicle Inspections Maintaining your vehicle's health is essential for both safety and longevity. Regular multi-point inspections...

Continue Reading